Publications by authors named "Inaki Elejalde"

Claim this Profile
L
Low rather than high interleukin-6 levels are associated with immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.
Iñigo Les, David de Haedo, Mireia Martínez, Berta Ibáñez-Beroiz, Amaia Moreno, Iñaki Elejalde

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective.
Lucía Teijeira, Mireia Martínez, Amaia Moreno, Ibone de Elejoste, Berta Ibáñez-Beroiz, Iñaki Elejalde

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events.
Iñigo Les, Mireia Martínez, Inés Pérez-Francisco, María Cabero, Lucía Teijeira, Iñaki Elejalde

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study.
Iñigo Les, Inés Pérez-Francisco, María Cabero, Cristina Sánchez, María Hidalgo, Iñaki Elejalde

Front Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylprednisolone Pulses in Hospitalized COVID-19 Patients Without Respiratory Failure: A Randomized Controlled Trial.
Iñigo Les, Jose Loureiro-Amigo, Ferran Capdevila, Isabel Oriol, Iñaki Elejalde

Front Med (Lausanne)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis